As of Nov 25
| -0.11 / -0.17%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 62.00, with a high estimate of 70.00 and a low estimate of 54.00. The median estimate represents a -3.82% decrease from the last price of 64.46.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.